• Citer

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

par Fernandez-Martinez, Aranzazu;Tanioka, M;Ahn, S G;Zagami, Paola;Pascual, T;Rediti, Mattia ;Tang, G;Hoadley, Katherine A;Venet, D;Rashid, N U;Spears, P A;Di Cosimo, S;de Azambuja, Evandro ;Choudhury, A;Rastogi, P;Islam, Md Naimul;Cortes, J;Llombart-Cussac, A;Swain, S M;Sotiriou, Christos ;Prat, A;Perou, Charles M;Carey, Lisa A
Référence Annals of oncology
Publication Publié, 2024-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).
Auteur:	Fernandez-Martinez, Aranzazu; Tanioka, M; Ahn, S G; Zagami, Paola; Pascual, T; Rediti, Mattia; Tang, G; Hoadley, Katherine A; Venet, D; Rashid, N U; Spears, P A; Di Cosimo, S; de Azambuja, Evandro; Choudhury, A; Rastogi, P; Islam, Md Naimul; Cortes, J; Llombart-Cussac, A; Swain, S M; Sotiriou, Christos; Prat, A; Perou, Charles M; Carey, Lisa A
Informations sur la publication:	Annals of oncology
Statut de publication:	Publié, 2024-12
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	HER2-positive early breast cancer
	gene expression
	genomic biomarkers
	post-treatment
	prognostic
	residual disease
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1016/j.annonc.2024.12.010
	info:pii/S0923-7534(24)04989-5
	info:pmid/39706338